Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cormedix Inc (NY: CRMD )

8.900 USD UNCHANGED
Last Price Updated: 8:00 PM EST, Feb 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cormedix Inc

< Previous 1 2 3 4 5 Next >
CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,... 
From GlobeNewswire News Releases
CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time 
From GlobeNewswire News Releases
Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,... 
From GlobeNewswire News Releases
CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,... 
From GlobeNewswire News Releases
CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,... 
From GlobeNewswire News Releases
CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,... 
From GlobeNewswire News Releases
Report: Exploring Fundamental Drivers Behind Allergan plc, Alamo Group, CorMedix, Foot Locker, Methode Electronics, and Motorcar Parts of America — New Horizons, Emerging Trends, and Upcoming Developm
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Allergan plc (NYSE:AGN),... 
From GlobeNewswire News Releases
Infection Control Seizes Headlines as Companies Look to Tackle Food-Borne Illnesses
FinancialBuzz.com News Commentary 
From PR Newswire
Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SS&C Technologies Holdings,... 
From GlobeNewswire News Releases
Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem — New Research Emphasizes Economic Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Hain Celestial Group,... 
From GlobeNewswire News Releases
Cormedix Receives Approval to Sell $5.4 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program
From ACCESSWIRE
Consolidated Research: 2018 Summary Expectations for Kadmon, Overstock, AECOM, Steelcase, CorMedix, and Corindus Vascular Robotics — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Kadmon Holdings, Inc.... 
From GlobeNewswire News Releases
CorMedix Inc. to Report Third Quarter 2018 Financial Results on Wednesday, November 14
From ACCESSWIRE
Data Projects the Global Medical Device Technologies Market to Grow $674 Billion by 2022
FinancialBuzz.com News Commentary 
From PR Newswire
Recent Analysis Shows Lantheus, Editas Medicine, CorMedix, DXP Enterprises, Peabody Energy, and CommScope Holding Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Lantheus Holdings, Inc.... 
From GlobeNewswire News Releases
Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products — Research Highlights Growth, Revenue, and Consolidated
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of C&J Energy Services, Inc.... 
From GlobeNewswire News Releases
Report: Exploring Fundamental Drivers Behind Chegg, C.H. Robinson Worldwide, Republic Services, CorMedix, Burlington Stores, and Etsy — New Horizons, Emerging Trends, and Upcoming Developments
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Chegg, Inc. (NYSE:CHGG),... 
From GlobeNewswire News Releases
Report: Exploring Fundamental Drivers Behind CorMedix, U.S. Silica, Zoetis, Kansas City Southern, Bemis, and Flowserve — New Horizons, Emerging Trends, and Upcoming Developments
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CorMedix Inc (NYSE:CRMD),... 
From GlobeNewswire News Releases
Investor Expectations to Drive Momentum within AVEO Pharmaceuticals, PTC Therapeutics, NGL Energy Partners LP, Bemis, CorMedix, and Patterson Companies — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AVEO Pharmaceuticals, Inc.... 
From GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within CorMedix, RPC, Royal Caribbean Cruises, Callaway Golf, CIT Group, and Cars.com – New Research Emphasizes Economic Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CorMedix, Inc. (NYSE:CRMD),... 
From GlobeNewswire News Releases
Technical Snapshots for These Biotech Stocks -- CorMedix, iBio Inc., ImmunoCellular Therapeutics, and Protalix BioTherapeutics
From PR Newswire
Stock Performance Review on Biotech Industry -- Intrexon, Ampio Pharma, AmpliPhi Biosciences, and CorMedix
From PR Newswire
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of CorMedix, Inc.
Levi & Korsinsky announces it has commenced an investigation of CorMedix, Inc. (NYSEMKT: CRMD) concerning possible breaches of fiduciary duty. 
From Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of CorMedix, Inc.
Levi & Korsinsky announces it has commenced an investigation of CorMedix, Inc. (NYSEMKT: CRMD) concerning possible breaches of fiduciary duty. 
From Business Wire News Releases
Research Reports Initiation on Biotech Stocks -- CorMedix, Trevena, Regulus Therapeutics, and ImmunoCellular Therapeutics
From PR Newswire
CorMedix Inc. Presentation Now Available for On-Demand Viewing
CorMedix Inc. (NYSE MKT: CRMD), based in Bedminster, NJ, focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today... 
From PR Newswire
Nasdaq, NYSE, OTC and Pre-IPO Companies to Present Online to Investors on July 14
PR Newswire and BetterInvesting (NAIC) today announced the agenda for the upcoming VirtualInvestorConferences.com, the evergreen online investor conference series. Individual investors, institutional... 
From PR Newswire
CorMedix Inc. to Webcast, Live, at VirtualInvestorConferences.com July 14
CorMedix Inc. (NYSE MKT: CRMD), based in Bedminster, NJ, focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today... 
From PR Newswire
CorMedix Inc. to Present Post-Market Clinical Utility Data from Neutrolin® Usage Monitoring Program on May 23, 2016
Data to be Presented at the 53rd Joint Congress of the European Renal Association - European Dialysis and Transplant Association 
From PR Newswire
CorMedix Inc. to Present New Pharmacoeconomic Data Demonstrating Cost of Catheter-Related Infections at the ISPOR 21st Annual International Meeting
Tags Banking & Financial Services Conferences
From ACCESSWIRE
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback